chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had fever, chill, fatigue, diarrhea and nausea on 11/10/2021. After 48 hour of my vaccine, the left side of my body became super painful and I was not able to move the left side of my body. I couldn?t lift my arm, turn my head and straighten my back and waist. Those symptom last for 24 hours until 11/12/2021.
Stiff neck.  Naperson 220 MG, Ibuprofin Headache:  Ibuprofin High Blood pressure:  Additional Toporol
At around 5:15 pm during observation Pt. complained of nausea/vomiting.  Cool water bottle applied to forehead.  Emesis basin offered, no vomiting.  Pt. was observed for additional 15 min.  No further symptoms observed/reported.  Stated feeling better. Parents educated to continue to monitor and to call physician or 911 for lift threatening.  Voiced understanding.
received vaccine Monday had a cough, but was doing well.  Then Weds cough worsened and did not sleep all night due to cough.  Thursday am ended up in the ER due to oxygen levels low at home.  In ER required oxygen and has never needed oxygen for pulmonary fibrosis thus far.   Admitted from Thursday till DC home Monday.    Oxygen still required.
Sore arm after second dose; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Sore arm after second dose) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after second dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment Information was provided by the reporter.  Patient took third dose on 13 Oct 2021.   This case was linked to MOD-2021-352991, MOD-2021-352996, MOD-2021-352613, MOD-2021-352622, MOD-2021-352623 (Patient Link).
patient reporting spot on arm the size of a quarter that appeared approximately two weeks after 2nd injection given.  She says it went from red and inflamed to white and flaky
redness and itching developed the day after vaccination. patient was prescribed antibiotics for the redness and, per patient report, was told that the dr suspected infection.
48hrs after the vaccine spiked a 103 fever right upper arm broke out in red rash, warm to the touch, sore arm. Took child into clinic on 12/5/18 after arm was not getting any better. Provider states it looks like hives and to give him BENADRYL.  Provider calling it an allergic reaction to the DtaP vaccine. After about 5 doses of BENADRYL the hives started clearing up.
It was basically just a headache and  lost of hunger. I basically survived four days on chicken noodle broth the worst headache ever had. On day four 17DEC2022 I had a COVID-19 Test-Positive.
Patient came to pharmacy 09/22/2021 saying he is still experiencing pain on his left arm following his flu shot on 09/07/2021. Claims that on night of 09/07/2021 and day after he experienced pain on injected site and arm. Pharmacist explained pain on arm and injection site may be expected following vaccine administration but patient claims the pain he experienced was more severe than what he has experienced following any other vaccinations. Says that he has tried OTC pain relief meds to address pain, also cold compresses, and mobilizing arm. Pain has subsided but is still present (although significantly less than when initially experienced) but claims has issues when he raises arm. Patient is retired paramedic and suspects injury to shoulder or nerve.
Information has been received from a physician concerning a female registered nurse (R.N.) from his office, who on 11-JUN-2007 was vaccinated subcutaneously with a "first vaccination of a single dose" of Zostavax (Oka/Merck). Two weeks following vaccination, (also reported as 16-Jul-2007) the patient experienced "pain in one of her eyes." The patient was seen by her optometrist who diagnosed her with herpes keratitis and was treated with antiviral eye drops. The virus was only directly in her eye. Specimens could not be obtained for analysis. A physician also reported that the patient had ophthalmic zoster. It is reported that the patient had corneal scarring. No product quality complaint was involved. Additional information has been requested. 12/21/07 This is in follow-up to report(s) previously submitted on 9/24/2007. The outcome is reported as not recovered.
Chills started at about 2am on 10/3 and lasted until I took advil at around 8am. I had fatigue all day and had no energy. On 10/4 at around 3am I had night sweats and was soaked in sweat when I was sleeping. That subsided when I woke up around 730am on 10/4
Information has been received from a physician via complete VZV questionnaire concerning a 64 year old female patient with peanut, soy and adhesive tape allergies and a history of chickenpox at childhood who on 19-MAR-2012 was vaccinated SQ in the left upper arm with a dose of ZOSTAVAX, 0.65ml (lot # 670816/0693AA). The physician mentioned that "2-3" days after vaccine administration, on approximately 21-MAR-2012 the patient got red, itchy, hot, swelling around the injection site about 1/4 inch to 3 inch in diameter, which lasted 2 weeks. On 21-MAR-2012, the patient got rash, swelling, hives and shortness of breath. The rash type was described as hives with a number of lesions of 10-20 on body, numerous times for the past 4 weeks of the time of report. The patient had no recent exposure to chickenpox. The patient went to the emergency room of an unidentified hospital for treatment and was prescribed prednisone (manufacturer unknown). At the time of the report, the patient was recovering, still having hives but improving on therapy. Other adverse effect's outcome was unknown. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wild-type (WT) VZV strain or with the Merck vaccine strain. A papula sample was collected on 16-MAY-2012. The sample was taken from the patient's right chest wall. The PCR result from the right chest wall specimen was inadequate specimen. The VZV DNA was not amplified. The beta-flobin DNA was not amplified. Follow up information has been received from a physician, refers to a 64 year old female patient (clerk) with none illness at the time of vaccination and none pre-existing allergies, birth defects and medical conditions (in previous version it was reported that patient has peanut, soy and adhesive tape allergies) who on 19-MAR-2012 was vaccinated subcutaneously in left upper arm with a dose of ZOSTAVAX, (dose not reported) Lot#670816/0693AA) by a pharmacy technician. On 21-Mar-2012 the patient experienced hives, shortness of breath, dyspnea on exertion and angioedema for 6 weeks post vaccination. It was reported that the patient required emergency room/doctor visit. CT scan, skin biopsy and unspecified lab test were performed (results not provided). On an unspecified date in June 2012 the patient recovered from hives, shortness of breath, dyspnea on exertion and angioedema. Reported terms "hives, shortness of breath, dyspnea on exertion and angioedema" were considered as disability and important medical events by reporter. Additional information has been requested.
After reviewing the camera, it was discovered that patient was given Prevnar 20 with needle pre-attached prior to the day vaccine was given. It was unclear how long the vaccine has been sitting in the fridge with needle attached before giving to patient. Pfizer manufacturer was contacted, product specialist did not have potency data on how long the vaccine is viable once seal is broken. Patient was then contacted due to sterility concern. Patient expressed that he is a dentist, he understands it was a honest mistake. He assures he does not feel the need to get re-vaccinated, and he has not experience any side effects since the day vaccine was given.
21OCT98 noticed soreness, minimal swelling, redness & inc warmth to area;sx began p/330PM;red area approx 5inches in length-5inch width;allergic rxn;
Vomited huge quantity while sleeping@ 10:45 pm. Responsive, but severely lethargic @ 10:05 vomited huge quantity again, then limp and unresponsive, color grey. Taken to ER by ambulance, Responded to 02, but still not alert, Slept between stimulation. Admitted to hospital for tests, released mid-day next day.
SEIZURE LASTING APPROXIMATELY 30 MINUTES, MEDICAL PERSONNEL CALLED TO PATIENT LOCATION AND PATIENT WAS TREATED/OBSERVED UNTIL PATIENT WAS CONSIDERED STABLE  AND COHERENT.
delerious; Fever; Rash; horrible body aches; Skin on fire; severe headache; pounding a rod into brain; dizzy; lack of concentration; eyes not dilating; ringing in ears; This spontaneous case was reported by a consumer and describes the occurrence of DELIRIUM (delerious) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced DELIRIUM (delerious) (seriousness criterion medically significant), PYREXIA (Fever), VACCINATION SITE RASH (Rash), PAIN (horrible body aches), SKIN BURNING SENSATION (Skin on fire), HEADACHE (severe headache), HEADACHE (pounding a rod into brain), DIZZINESS (dizzy), DISTURBANCE IN ATTENTION (lack of concentration), MIOSIS (eyes not dilating) and TINNITUS (ringing in ears). At the time of the report, DELIRIUM (delerious), PYREXIA (Fever), VACCINATION SITE RASH (Rash), PAIN (horrible body aches), SKIN BURNING SENSATION (Skin on fire), HEADACHE (severe headache), HEADACHE (pounding a rod into brain), DIZZINESS (dizzy), DISTURBANCE IN ATTENTION (lack of concentration) and MIOSIS (eyes not dilating) outcome was unknown and TINNITUS (ringing in ears) had not resolved.            This case concerns a 62-year-old female with a serious unexpected event of delirium, and nonserious unexpected dizziness, pain, skin burning sensation, disturbance in attention, miosis, tinnitus, and expected fever, headache, vaccination site rash. Event onset 2 days after second dose mRNA-1273. Event outcomes ongoing or unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 62-year-old female with a serious unexpected event of delirium, and nonserious unexpected dizziness, pain, skin burning sensation, disturbance in attention, miosis, tinnitus, and expected fever, headache, vaccination site rash. Event onset 2 days after second dose mRNA-1273. Event outcomes ongoing or unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Mild shoulder muscle soreness at site injection day of 2nd dose; next day, lymph node (underarm) was noticeably swollen to the size of a small orange - symptom began to subside by morning of 3/15/21.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 18-MAY-2015 the patient was vaccinated with a dose of PROQUAD (Merck), lot # L003221, expiration date 30-JUL-2016 (dose and route not reported), which was improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Swollen lymph node of armpit of the arm that was injected. It was injected higher on the arm (more on the shoulder) than the 1st dose. The symptom went away after a week. I just noticed it was not a commonly reported symptom, and I thought I should add this information. I don't know if higher placement of injection could have contributed to it. This isn't a complaint; I am just doing my part of contributing the data to compile on the drug
Information has been received from a nurse practitioner concerning a 6 month old male infant with no known allergies or pertinent medical history who on an unspecified date was vaccinated orally with 2ml of ROTATEQ (Oka/Merck) (lot # 660679/0407X). There was no concomitant medication. Subsequently, the week of 23-JUN-2008 the patient developed watery stools approximately 24 hours after vaccination. Medical attention was sought, the office was called. There were no lab studies performed. At the time of the report the patient was recovering. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source. This is in follow-up to report (s) previously submitted on 7/15/2008. Follow-up information has been received from a nurse practioner concerning this 6 month old male infant with no known allergis and grade 11 vesicureteral reflux who on 23-2008 was vaccinated orally in the AM with a third dose of ROTATEQ (lot # 660596/0211X) (previously reported as lot # 660679/0407X). There was no illness at the time of vaccination or any adverse events following prior vacciantion. Subsquently. On the same day of vaccination the patient started having 4 - 6 watery stools daily. There were no lab activities performed. At the time of the report, the patient recovered in 4 - 5 days on approximately 27-Jun-2009. It was reported that the diarrhea resolved without treatment. Additional information is not expected. This is one of several reports from the same source.
Fever, chills, lightheaded, trouble breathing, feeling flushed, shaking.
Chest congestion within 10 minutes needing to clear with cough.; Chest congestion within 10 minutes needing to clear with cough.; Then sinus swelling lasted for around 26 hour.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 01Apr2021 at 10:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin, sulfa and many side effects to other medications, soaps and cleaners. The patient had known allergies to erythromycin but no food allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN), curcuma longa rhizome (TURMERIC) and omeprazole (GENERIC PRILOSEC); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 10:45, within 10 minutes of vaccination, the patient experienced chest congestion needing to clear with cough which lasted for hour in half and sinus swelling that lasted for around 26 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest congestion needing to clear with cough which lasted for hour in half was recovered on 01Apr2021; while that of the sinus swelling that lasted for around 26 hours was recovered on 02Apr2021.  No follow-up attempts are needed. No further information is expected.
Started having full body muscle spasms, pulling me into a fetal position for approx 2 hours, then the spasms intensified and the muscles in my legs, feet, and toes tensed up so bad, pulling my feet and toes into different directions to the point I thought it was going to either break or dislocate my toes and ankles. The muscles were so tight my circulation was cut off, and my feet/toes were purple. I started convulsing all over my body. Head to my legs. All I could do was scream, cry, and beg God to make it stop. This lasted 9 hours. The following morning my neck muscle, to the left side of my spine started hurting, it got worse throughout the day. I took prescription strength ibuprofen, used muscle rub, neck massage, and a tens unit. But it continued to worsen. By the afternoon I could no longer move my head at all. My pcp told me to go to the ER.  I was given 2 doses of roboxin, morphine & a bag of IV fluids. After about 4 hours it finally started to ease up and I could move my head a little. By the next day I could move my neck normally. My PCP has advised me not to get the 2nd dose. To this day I am still having muscle spasms, however they are tolerable.
Injection site pain that lasted about three days, day one was the worst. Fever of 100.5F, muscle pain, chills, and joint pain on the third day and lasted around six hours. Loss of appetite and nausea lasted about a week. Tiredness and headache lasted almost two weeks.
Shortly after receiving vaccinations, patient became pale and diaphoretic. He was transported to the triage area, placed in a supine position with his legs elevated and was observed until his blood pressure came back up. He was given juice and crackers.
This case involves a 19-year-old female patient who vaccinated with one dosage form (once) of expired MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (single use vial, strength: 0.5 mL, lot U6787AA, expiry date 08-Nov-2021) via intramuscular route in the left deltoid on 28-Nov-2021 for prophylactic vaccination (expired product administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication reported no other vaccines. It was a case of actual medication error due to expired vaccine used (latency was on same day). It was reported "The caller reports an expired vaccine was administered to a patient, does it need to be repeated? Is this dose valid and when should the patient get the next dose?" At the time of report, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This is a spontaneous report from a contactable nurse received via a sales representative. A patient of unspecified age, ethnicity and gender received TRUMENBA on an unspecified date, at single dose. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced body aches and chills on an unspecified date after vaccination, with unknown outcome. Follow-up (08MAY2016): Follow-up attempts are completed. No further information is expected.
Within approx 20 min. pt complained of severe headache, vomited, became lethargic and then developed red, watery eyes, puffy face and covered in hives. Resolved after few hours with steroids and antihistamines.
Pain in injection site; Muscle aches; Upset stomach; Chills; This case was reported by a consumer and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th October 2019, the patient received Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced injection site pain, muscle pain, upset stomach and chills. On an unknown date, the outcome of the injection site pain, muscle pain, upset stomach and chills were unknown.   It was unknown if the reporter considered the injection site pain, muscle pain, upset stomach and chills to be related to Shingrix.  Additional details were received as follows: The patient stated, she got the Shingrix injection the day before the reporting date. She experienced a bad side effects which included pain in injection site, muscle aches, upset stomach, chills. The patient did not think, she had a fever yet. She asked, how long these side effects would stay.
Patient states that her arm has been sore since the date she received her vaccine. Stated limited range of motion, unable to carry heavy items, and the pain waking her up at night. Patient advised to ice the arm and try taking NSAID/ tylenol to help with the pain. If no improvement, make an appointment with PCP.
Information has been received from a nurse concerning several (3-4) female patients who on an unspecified date were vaccinated in the first dose of Gardasil (Lot # not reported). The nurse reported that a few minutes after receiving the vaccination the patients had "near fainting episodes". The patients had recovered from the events. She stated that she works in a large clinic and they have now made it a policy to observe the patients for 20 to 30 post vaccination. Additional information has been requested.
A bit over an hour after the vaccine my heart rate went to 202 beats. I was not light headed, didn?t feel bad but my heart started beating fast and went to 202bpm . I checked it on my finger pulse oximeter. It lasted about a minute I coughed and bear down and heart rate went back down. The next day I didn?t feel well, red rash about an inch or two below injection site, headache, tired, arm sore and temperature of 99.8.
ACUTE MI 6/26/2022 ACUTE CHF, UNSPECIFIED  ACUTE CORONARY SYNDROME, UNSPECIFIED 7/3/2022 ACUTE CHF, UNSPECIFIED  ACUTE MI 6/26/2022 CHEST PAIN  ACUTE CORONARY SYNDROME, UNSPECIFIED 7/3/2022 CHEST PAIN  ACUTE MI 6/26/2022 AMYLOIDOSIS, UNSPECIFIED  ACUTE CORONARY SYNDROME, UNSPECIFIED 7/3/2022 AMYLOIDOSIS, UNSPECIFIED  ACUTE MI 6/26/2022 DYSPNEA  ACUTE CORONARY SYNDROME, UNSPECIFIED 7/3/2022 DYSPNEA
Information has been received from a physician concerning a female patient who was vaccinated with two doses of GARDASIL.  On an unspecified date, the patient tested positive for Papilloma viral infection (HPV), type unspecified.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Case number PHEH2012US016709 is an initial spontaneous report received from a nurse on 21 Aug 2012 with the follow-up received on 17 Sep 2012: This report refers to an 18-year-old female patient. She was given only the CYW-135 liquid component of MENVEO (batch number: M10047) intramuscularly on 21 Aug 2012. She was revaccinated with full dose of MENVEO (batch number: M11082) at dose of 0.5 ml intramuscularly on 23 Aug 2012. No other adverse reaction was reported following this administration error. Follow-up received on 17 Sep 2012: Updated patient initials, weight and height and revaccinated details (MENVEO).
Patient in for vaccines, as requested to split up shots due at 1 yr. MMR, Varicella, Hep A and Influenza ordered and given. During routine paperwork discovered 2nd MMR had been given on Oct. 7, 2011.
Covid vaccine recieved 3/31/21. Dysport recieved 04/07/21. At approximately 430am, I awoke to full body tremors, fever, extremely hot face, inability to control body movements. Lasted approximately 2 hours.